Intensive chemotherapy for metastatic nonseminomatous germ cell tumors

Prog Clin Biol Res. 1990:350:301-7.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / blood
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Chorionic Gonadotropin / blood
  • Chorionic Gonadotropin, beta Subunit, Human
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Drug Evaluation
  • Female
  • Humans
  • Indiana / epidemiology
  • Male
  • Neoplasms, Germ Cell and Embryonal / blood
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Neoplasms, Germ Cell and Embryonal / mortality
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Peptide Fragments / blood
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Texas / epidemiology
  • Vinblastine / administration & dosage
  • Vinblastine / adverse effects

Substances

  • Biomarkers, Tumor
  • Chorionic Gonadotropin
  • Chorionic Gonadotropin, beta Subunit, Human
  • Peptide Fragments
  • Bleomycin
  • Vinblastine
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin

Supplementary concepts

  • CISCA(II)-VB(IV) protocol